Andre Aarøen
Vorsitzender bei Flåmsbrygga Hotell AS
Profil
Andre Aarøen is currently the Chairman of Flåmsbrygga Hotell AS and Defibrio AS.
Aktive Positionen von Andre Aarøen
| Unternehmen | Position | Beginn |
|---|---|---|
Flåmsbrygga Hotell AS
 Flåmsbrygga Hotell AS Hotels/Resorts/Cruise linesConsumer Services Flåmsbrygga Hotell AS is a private company based in Flåm, Norway. Flåmsbrygga Hotell AS operates hotels, boarding houses, and motels. The Norwegian company was founded in 2014 and is led by CEO Aud Melås. | Vorsitzender | - |
Defibrio AS
 Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Vorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Flåmsbrygga Hotell AS
Flåmsbrygga Hotell AS Hotels/Resorts/Cruise linesConsumer Services Flåmsbrygga Hotell AS is a private company based in Flåm, Norway. Flåmsbrygga Hotell AS operates hotels, boarding houses, and motels. The Norwegian company was founded in 2014 and is led by CEO Aud Melås. | Consumer Services |
Defibrio AS
Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Health Technology |
